Review
Open access
Aug 2026
CAR-T cells and CAR-Treg cells for treatment of inflammatory bowel diseases
In parallel, CAR regulatory T cells (CAR Tregs) may offer a complementary approach for IBD therapy by redirecting suppressive immune function in the inflamed intestine and provide a mechanistically attractive strategy to modulate T helper–type 17-driven mucosal inflammation in CD.
M. Neurath
· EULAR rheumatology open · 0 citations